NEW YORK, May 7 – Nucleic acid handling company Qiagen said Monday its first quarter revenues rose 26 percent to $63.1 million, compared with $50.2 million in the year ago quarter.

Total operating expenses increased 27 percent to $34.3 million, compared with $27 million in the year ago period, as research and development, sales and marketing, and general and administrative costs rose across the board. Qiagen of Venlo, The Netherlands, also posted expenses totaling $3 million stemming from the acquisition of Japan’s Sawady group of companies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.